Uncover key drivers, emerging technologies, and competitive movements shaping the contract research and manufacturing services (crams) market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Contract Research And Manufacturing Services (CRAMS) Market by the end of 2030?
The market size for contract research and manufacturing services (crams) has expanded rapidly in recent years. It is projected to grow from $155.61 billion in 2025 to $171.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. This historical growth can be attributed to several factors including rising R&D costs within the pharmaceutical sector, increasing demand for innovative drugs, limitations in in-house manufacturing capabilities, growing regulatory complexities, and the emergence of biotechnology companies.
The contract research and manufacturing services (crams) market is projected to experience swift expansion in the coming years. This market is anticipated to reach $258.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. Key factors contributing to this anticipated growth include the rising adoption of biologics and advanced therapies, the expanding scope of clinical trial outsourcing, the increasing need for personalized medicine, advancements in manufacturing automation technology, and the growing prevalence of contract manufacturing for medical devices. Significant trends observed during this period encompass the outsourcing of pharmaceutical R&D, the broadening of biologics manufacturing services, a heightened demand for analytical testing and quality control, an increase in custom synthesis and production services, and the continuing rise in contract manufacturing for medical devices.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6041&type=smp
What Drivers Are Shaping Future Opportunities In The Contract Research And Manufacturing Services (CRAMS) Market?
The increasing ageing population, coupled with a rise in various chronic diseases, is expected to positively impact the growth of the contract research and manufacturing services (CRAMS) market during the forecast period. The world’s ageing population is expanding rapidly and is projected to continue doing so throughout the forecast period. With the growth in the geriatric population, the prevalence of conditions such as cancer, diabetes, Alzheimer’s, arthritis, and other diseases will also rise, consequently increasing the demand for various drugs or medicines. This will lead to an increased need for contract research and manufacturing services. For example, in September 2023, according to the Australian Bureau of Statistics, an Australia-based statistical agency, Australia’s population, which stood at 26 million in 2022, is expected to grow to between 34.3 million and 45.9 million by 2071. Furthermore, the median age, currently 38.5 years, is projected to increase to between 43.8 and 47.6 years. Thus, the growing ageing population will drive the growth of the contract research and manufacturing services (CRAMS) market.
Which Segment Groups Are Influencing The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (crams) market covered in this report is segmented –
1) By Services: Manufacturing, Research
2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes
3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging
Subsegments:
1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production
2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services
Which Trends Are Guiding The Evolution Of The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (CRAMS) market is increasingly leveraging artificial intelligence (AI) to strengthen its market position. Artificial intelligence is a field of computer science that deals with replicating human behavior in machines. AI can assist in avoiding costly maintenance by predicting when it is required and by supporting the healthcare system. For example, in June 2024, Medidata, a US-based technology company, launched the Medidata Clinical Data Studio, which focuses on integrating and managing clinical trial data from various sources to enhance the efficiency and accuracy of clinical research. It employs artificial intelligence to simplify data review and reconciliation, allowing study teams to more effectively detect potential data issues and safety signals. The platform offers a comprehensive workspace for data integration, transformation, and management, enabling users to adopt strong risk-based quality management strategies and gain access to real-time insights.
Who Are The Top-Performing Companies In The Contract Research And Manufacturing Services (CRAMS) Market In Recent Years?
Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Contract Research And Manufacturing Services (CRAMS) Market?
North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in the contract research and manufacturing services (crams) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Contract Research And Manufacturing Services (CRAMS) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6041&type=smp
Browse Through More Reports Similar to the Global Contract Research And Manufacturing Services (CRAMS) Market 2026, By The Business Research Company
Contract Research And Manufacturing Services Market Report 2026
Contract Development Manufacturing Organizations Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model